Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Foreign Service Institute Director Polaschik Travels to France and Jordan
    Foreign Service Institute Director Polaschik Travels to France and Jordan World News
  • America’s Tallest Digital Countdown Clock & Fireworks Light-Up Paramount Miami Worldcenter Tower
    America’s Tallest Digital Countdown Clock & Fireworks Light-Up Paramount Miami Worldcenter Tower World News
  • How to Get the Most Out of a New Job Offer
    How to Get the Most Out of a New Job Offer Business
  • War Day 164: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych  & #Feygin
    War Day 164: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • War Day 224: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 224: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • High-level U.S. Government Delegation Travel to Addis Ababa, Ethiopia
    High-level U.S. Government Delegation Travel to Addis Ababa, Ethiopia World News
  • War in Ukraine, Analytics. Day 1048: Zelensky’s Interview with Lex Fridman. Arestovych, Feldman
    War in Ukraine, Analytics. Day 1048: Zelensky’s Interview with Lex Fridman. Arestovych, Feldman World News
  • Golovanov #26: All Ukrainian Troubles Stem From Self-Betrayal
    Golovanov #26: All Ukrainian Troubles Stem From Self-Betrayal World News
PATENT AND TRADEMARK OFFICE OFFICIALLY ACCEPTS RENEWAL OF REGISTRATION FOR THE AKELOS TRADEMARK

PATENT AND TRADEMARK OFFICE OFFICIALLY ACCEPTS RENEWAL OF REGISTRATION FOR THE AKELOS TRADEMARK

Posted on January 17, 2025 By NewsEditor

THE RENEWAL OF THE AKELOS REGISTRATION FOR ANOTHER 10 YEARS SOLIDIFIES THE ORGANIZATION’S BRAND IDENTITY, PROVIDES ENHANCED LEGAL PROTECTION.

NEW YORK CITY, NEW YORK, UNITED STATES, January 10, 2025 /EINPresswire.com/ — Akelos Inc. Receives USPTO Renewal of Trademark
________________________________________

Akelos Inc. is proud to announce that the United States Patent and Trademark Office has officially accepted the renewal of the registration for the AKELOS trademark. Based on the acceptance of the Section 15 Reiteration of Incontestibility and Section 8 Declaration of Use, the renewal of the AKELOS registration for another 10 years solidifies the organization’s brand identity, provides enhanced legal protection, and paves the way for continued growth and expansion.

Founded in 2018, Akelos Inc. is a biotechnology company currently developing and commercializing a novel, non-opioid anti-hyperalgesic drug to treat chronic and neuropathic pain. The name “Akelos” is derived from the Greek words ἄκη (aké), meaning “cure” or “remedy” in ancient Greek, and ἄχος (áchos), meaning “pain” or “grief.”

“We’re absolutely delighted to complete this company milestone,” said Dr. Steven Fox, Chairman of Akelos Inc.

“We believe that our company’s name is something that physicians, patients, payors, and investors can connect with our mission of supporting the growing number of patients who suffer from neuropathic pain, a taxing condition with limited treatment options.”

This trademark registration represents an important step forward for Akelos Inc., strengthening its foundation as the company progresses in developing innovative treatments for neuropathic pain. With its official trademark registration renewed, Akelos remains committed to its mission of addressing the unmet needs of patients suffering from chronic pain conditions.

________________________________________

About Akelos

Akelos Inc. is engaged in a research collaboration with Weill Cornell Medicine to develop a unique receptor-targeting platform technology. The lead asset from the platform is a first-in-class, non-opioid drug with a novel mechanism of action, designed specifically for the non-addictive treatment of neuropathic pain. For more information, visit www.akelosinc.com or connect with us on LinkedIn.

________________________________________

Akelos Forward-Looking Statement

This press release contains forward-looking statements. These forward-looking statements are based on management’s expectations and are subject to certain factors, risks, and uncertainties that may cause actual results, outcomes of events, timing, and performance to differ materially from those expressed or implied by such statements. The information contained in this press release is believed to be current as of the date of issuance. Akelos Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to forward-looking statements contained herein to reflect changes in our expectations or changes in events, conditions, or circumstances on which such statements are based.

These statements include, among others, those related to the results of research and development activities; uncertainties relating to preclinical and clinical testing; the cost, timing, and outcome of the regulatory development and approval process; budgets, expenditures, and financing plans; the need for substantial additional funds; patent and intellectual property matters; reliance on third parties, including contract research and contract clinical trial organizations; and market opportunity and competition.

________________________________________

Investor Contact:

Office of Dr. Steven Fox

Phone: +1 212-953-1544

Email: drstevefox@akelosinc.

dr steven fox
akelosinc
2129531544
[email protected]
Visit us on social media:
Facebook
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

PATENT AND TRADEMARK OFFICE OFFICIALLY ACCEPTS RENEWAL OF REGISTRATION FOR THE AKELOS TRADEMARK

You just read:

News Provided By

January 10, 2025, 20:21 GMT


EIN Presswire’s priority is author transparency. We do our best to weed out false and misleading content. The content above is
the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.

Article originally published on www.einpresswire.com as PATENT AND TRADEMARK OFFICE OFFICIALLY ACCEPTS RENEWAL OF REGISTRATION FOR THE AKELOS TRADEMARK

World News

Post navigation

Previous Post: Experienced Congressional Legislative Director Joins HBS Federal Team
Next Post: Drone Flight Controller System Market USD 13.8 Billion by 2032, Industry Compound Annual Growth Rate of 8%

Related Posts

  • US. Department of Homeland Security and Finnish Ministry of the Interior enhance internal security cooperation
    US. Department of Homeland Security and Finnish Ministry of the Interior enhance internal security cooperation World News
  • Emma Stone and Emma Thompson on Gossip Stone TV Celebrity Show
    Emma Stone and Emma Thompson on Gossip Stone TV Celebrity Show World News
  • War Day 70: war diaries w/ Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Фейгин
    War Day 70: war diaries w/ Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Фейгин World News
  • Non-Woven Fabrics Market Size, Share And Growth Analysis For 2023-2032
    Non-Woven Fabrics Market Size, Share And Growth Analysis For 2023-2032 World News
  • Digital Railway Global Market 2024 To Reach .83 Billion By 2028 At Rate Of 11.2%
    Digital Railway Global Market 2024 To Reach $90.83 Billion By 2028 At Rate Of 11.2% World News
  • Digital Railway Global Market 2024 To Reach .83 Billion By 2028 At Rate Of 11.2%
    Rising Cancer Incidence And Its Impact On Market World News
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« May    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Market Share, Segments, and Emerging TrendsJune 23, 2025
  • IMPORTANT NOTICE TO ARMADA WASTE MANAGEMENT/GPB WASTE MANAGEMENT INVESTORS WHO SUFFERED LOSSESJune 23, 2025
  • R2 Recycling Expands E-Waste Pickup Services for Businesses & SchoolsJune 23, 2025
  • IMPORTANT NOTICE TO GPB NYC DEVELOPMENT INVESTORS WHO SUFFERED LOSSESJune 22, 2025
  • Alexander Döll Appointed CEO of the Methanol InstituteJune 22, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Online Clothing Rental Market Size
    Online Clothing Rental Market Size Business
  • Rev. Werner Trapp BBR Unveils New Book, “From the End Time to Heaven”
    Rev. Werner Trapp BBR Unveils New Book, “From the End Time to Heaven” World News
  • Digital Railway Global Market 2024 To Reach .83 Billion By 2028 At Rate Of 11.2%
    Comprehensive Analysis Of Key Market Trends, Growth Drivers, And Leading Companies World News
  • Foreign Service Institute Director Polaschik Travels to France and Jordan
    U.S. and North Macedonia Co-Host Proliferation Security Initiative Workshop World News
  • Starrag Continuously Increases Its Commitment to Customers in North America and Mexico
    Starrag Continuously Increases Its Commitment to Customers in North America and Mexico Business
  • City of Winter Park, FL, Expands OpenGov Partnership to Facilities Asset Management
    City of Winter Park, FL, Expands OpenGov Partnership to Facilities Asset Management World News
  • Secretary Antony J. Blinken Opening Remarks Before the Senate Committee on Foreign Relations On the FY24 Department of State Budget Request
    Secretary Antony J. Blinken Opening Remarks Before the Senate Committee on Foreign Relations On the FY24 Department of State Budget Request World News
  • Increased Sun Exposure And Tanning Habits of Individuals
    Increased Sun Exposure And Tanning Habits of Individuals World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .